Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intra-Cellular Ther
(NQ:
ITCI
)
74.48
+0.12 (+0.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Intra-Cellular Ther
< Previous
1
2
3
4
5
Next >
45 Biggest Movers From Yesterday
January 05, 2022
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 04, 2022
Gainers Hoth Therapeutics (NASDAQ:
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
January 04, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...
Via
Benzinga
Analyst Ratings For Intra-Cellular Therapies
December 20, 2021
Within the last quarter, Intra-Cellular Therapies (NASDAQ:ITCI) has observe...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 04, 2022
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 68.7% to $1.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $28....
Via
Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
January 04, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc...
Via
Benzinga
IntraCellular Seeks To Raise $400M Via Equity To Fund Commercialization Of Schizophrenia Med
January 04, 2022
Intra-Cellular Therapies Inc (NASDAQ: ITCI) commenced an underwritten public offering of $400 million of shares. Underwriters have an option to purchase up to an...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Up Ahead Of Manufacturing Report
January 04, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones and S&P 500 closed at fresh highs on the first trading day of new year....
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
5 Stocks To Watch For January 4, 2022
January 04, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects SMART Global Holdings, Inc. (NASDAQ: SGH) to report quarterly earnings at $2.00 per share on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 03, 2022
Gainers Indaptus Therapeutics (NASDAQ:INDP
Via
Benzinga
65 Biggest Movers From Yesterday
December 21, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
December 20, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF...
Via
Benzinga
FDA Approves Intra-Cellular's Antipsychotic For Bipolar Depression
December 20, 2021
The FDA has approved Intra-Cellular Therapies Inc (NASDAQ: ITCI) Caplyta for depressive episodes associated with bipolar I or II disorder in adults. The approval...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 20, 2021
Gainers Intra-Cellular Therapies (NASDAQ:ITCI) stock rose 18.79% to $46.52 during Monday's pre-market session. The market value of their outstanding shares is at $3.7...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 20, 2021
The weekend break is over and that means it's time to get back to work with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...
Via
Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple...
Via
Benzinga
Exposures
Product Safety
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for...
Via
Benzinga
Exposures
Product Safety
Looking Into Intra-Cellular Therapies's Return On Capital Employed
November 10, 2021
Benzinga Pro data, Intra-Cellular Therapies (NASDAQ:ITCI) reported Q3 sales of $22.21 million. Earnings fell to a loss of $77.32 million, resulting in a 11.83% decrease from last...
Via
Benzinga
Intra-Cellular Therapies inc (ITCI) Q3 2021 Earnings Call Transcript
November 09, 2021
ITCI earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Intra-Cellular Therapies: Q3 Earnings Insights
November 09, 2021
Intra-Cellular Therapies (NASDAQ:ITCI) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM. Here's what investors need to know about the...
Via
Benzinga
Looking Into Intra-Cellular Therapies's Return On Capital Employed
September 20, 2021
Intra-Cellular Therapies (NASDAQ:ITCI) brought in sales totaling $20.05 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 29.92%, resulting...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:
Via
Benzinga
Why Intra-Cellular Therapies Was Weak This Week
August 13, 2021
The company's second-quarter net loss was a bit deeper than analysts expected.
Via
The Motley Fool
Intra-Cellular Therapies inc (ITCI) Q2 2021 Earnings Call Transcript
August 09, 2021
ITCI earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Intra-Cellular Therapies: Q2 Earnings Insights
August 09, 2021
Shares of Intra-Cellular Therapies (NASDAQ:ITCI) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share rose 11.46% over the past year...
Via
Benzinga
Pandemic Fallout: 6 Mental Health Stocks To Watch
June 28, 2021
One of the most devastating long-term impacts of the COVID-19 pandemic may be the toll it has taken on people’s mental health. The next globa...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For August 9, 2021
August 09, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...
Via
Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.